News

Lisata Therapeutics to Showcase Innovations at BIO Convention

Lisata Therapeutics to Showcase Innovations at BIO Convention

Basking Ridge, N.J. - Lisata Therapeutics Overview

Lisata Therapeutics, Inc. (NASDAQ: LSTA) is making strides in the fight against severe diseases. As a clinical-stage pharmaceutical company, Lisata focuses on developing breakthrough therapies specifically for advanced solid tumors. The company is on the cusp of sharing significant insights about its transformative work at the highly anticipated 2025 BIO International Convention.

Upcoming Presentation Details

David J. Mazzo, Ph.D., the President and CEO of Lisata Therapeutics, will deliver a corporate overview during the BIO International Convention. This notable event is set to take place from June 16 to June 19, 2025, in Boston. Dr. Mazzo's presentation is scheduled for June 17 at 11:15 a.m. Eastern Time in Room 153A. This presentation will provide attendees with insights into the innovative approaches Lisata is undertaking in oncology.

Conference Engagement

Those interested in learning more about Lisata’s advancements are encouraged to register for the convention. Attendees can also schedule one-on-one meetings with company management, facilitating deeper discussions about their research and innovations. More information can be found on the official BIO website.

About Lisata Therapeutics

Lisata Therapeutics is at the forefront of developing effective solutions for some of the most pressing health challenges. The company is dedicated to discovering, developing, and commercializing innovative therapies, particularly addressing advanced solid tumors and critical diseases. One of their leading candidates, certepetide, aims to improve cancer treatment by enhancing the delivery of anti-cancer drugs directly to tumors.

Groundbreaking Therapies

Certepetide represents a significant leap in cancer therapy, as it is designed to activate a specialized pathway enabling better targeting of solid tumors by anti-cancer agents. This innovative approach is expected to enhance the efficacy of combined treatments, marking a promising advancement over traditional therapies.

Partnerships and Collaborations

Lisata Therapeutics has forged essential research and development partnerships that bolster its mission. The strategic collaborations enable them to accelerate development timelines, ensuring that more patients gain access to innovative therapies in their fight against cancer.

Future Milestones

Looking ahead, Lisata is set to announce numerous milestones crucial for the trajectory of its ongoing clinical trials. The company believes that its current financial resources will sustain operations through late 2026, allowing them to focus on forthcoming data announcements related to pivotal clinical outcomes.

Educational Resources

Educating stakeholders about their innovative approaches is a core component of Lisata’s strategy. The company has created engaging content, including a short film that illustrates certepetide’s mechanism of action, which highlights how it could revolutionize treatment strategies in oncology.

Connect with Lisata Therapeutics

For those eager to learn more about the groundbreaking work at Lisata Therapeutics, the company's website provides a wealth of information detailing their research initiatives and educational resources. As Lisata continues to grow and evolve, they remain at the cutting edge of cancer treatment innovation.

Frequently Asked Questions

What is Lisata Therapeutics focused on?

Lisata Therapeutics specializes in developing therapies for advanced solid tumors and other severe diseases.

When will Lisata present at the BIO International Convention?

David J. Mazzo, Ph.D., will present at 11:15 a.m. on June 17, 2025.

What is certepetide?

Certepetide is an investigational drug developed by Lisata to enhance the delivery of anti-cancer therapies directly to solid tumors.

How can one register for the BIO International Convention?

Registration information is available on the official BIO website for those interested in attending the convention.

Who can I contact for more information about Lisata Therapeutics?

Individuals can reach out to John Menditto, Vice President of Investor Relations, at 908-842-0084 or via email at jmenditto@lisata.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Walmart Tops 2026 Recall List: 81 Notices, Food Issues Lead

Updated Category News Views 72

Walmart Behind 81 Recalls: Scrutinizing 2026's Top Contender For an outfit that prides itself on shaking up shopping carts coast to coast, Walmart's stumble onto the recall hotseat this year is a head-scratcher. Imagine leading with 81 official recalls—that's more than a flash in the pan, it's the whole frying pan catching fire. Target and Costco aren't slouches, but...

Continue Reading
AppLovin Faces Serious Investor Lawsuit Deadline

Updated Category News Views 157

Investors' Trust Shaken: The AppLovin Controversy Well, what do we have here? Another day, another hefty lawsuit coming down the pike. The spotlight’s on AppLovin Corporation (NASDAQ: APP), where the Hagens Berman law sharks are sniffing blood in the water over what they claim are federal securities law violations. The core of this legal storm swirls around AppLovin's...

Continue Reading
Betterness Expands Health Networks with $3.5M Boost

Updated Category News Views 55

Defining a Health Revolution in the Heart of Miami Just when you think the fitness tech scene might be settling into its groove, along comes Betterness, Inc., shaking things up with another cool million in their pockets. I'm talking about their recent addition to their seed round, now sitting pretty at a robust $3.5 million. You can't ignore how they're taking a...

Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss

Updated Category News Views 124

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Continue Reading
AI-Driven Software Growth Faces Profitability Hurdles

Updated Category News Views 115

AI and Growth: A Tale of Two Strategies Is AI the superhero we’ve been waiting for, or just another fad? The KeyBanc Capital Markets' 2026 AI x Software Benchmark throws more questions into the ring than it answers. This benchmark isn't just numbers on a page; it's a pulse check on how AI is reshaping the software landscape. Seeing AI-native firms grow at a dizzying 34%...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 72

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Maritime Launch's Bold Q3 Surge Amid Space Race

Updated Category News Views 193

Rockets, Revenue, and a Bold New Path You ever hear about a spaceport tucked away in the toes of Nova Scotia, making waves with its third-quarter earnings? Well, that's exactly what's cooking over at Maritime Launch Services. These folks have managed to turn a zero into hero in a flash, reporting $5.6 million in revenue and a snug $3.5 million in net income for Q3 2026....

Continue Reading
NueSynergy Secures Top Spot in HSA Provider Rankings

Updated Category News Views 162

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Continue Reading
Where Winds Meet Celebrates 1st Anniversary With New Region

Updated Category News Views 92

A Staggering Universe Deepens: Hutuo's Introduction Just when you think you've seen it all, NetEase Games and Everstone Studio go and launch Hutuo, a compelling addition to the already sprawling universe of Where Winds Meet. On the occasion of its first global anniversary, this epic Wuxia ARPG throws players into the mud-soaked, steel-clashing chaos of a warzone, testing...

Continue Reading
Timken Maintains Robust Dividend Streak in 2026

Updated Category News Views 134

Timken Keeps Dividend Train Rolling You want to talk consistency? Timken Company just declared its quarterly dividend like clockwork. As a stockholder, that might just be your morning coffee fix before anything else. Notably, Timken's been on the NYSE since 1922, having cranked out 418 consecutive dividend payouts. That's like your grandpa never missing a Sunday golf...

Continue Reading

Top 5 Most Recently Viewed Articles

Kichler and Progress Lighting Launch Unified Exhibit at KBIS 2026

Updated Category News Views 140

Unified Lighting Design Experience at KBIS 2026 Join Kichler and Progress Lighting as they unveil a fresh and innovative lighting showcase at KBIS 2026. The collaborative effort of these two leading brands marks a significant milestone in their ongoing commitment to revolutionizing modern living spaces through exceptional design. For the very first time, they will jointly...

Continue Reading
Blend Labs to Announce Year-End Financial Results Soon

Updated Category News Views 255

Blend Labs Announces Upcoming Financial Results Blend Labs, Inc. (NYSE: BLND), recognized as a leader in digital banking solutions, is preparing to release its financial results for the fourth quarter and full year of 2024. This announcement comes as the company continues to excel in providing innovative banking technologies to various financial institutions. Schedule for...

Continue Reading
Psilera Inc. Receives NIH Grant for Innovative Alcohol Treatment

Updated Category News Views 132

Psilera Inc. Advances Alcohol Use Disorder Research Psilera Inc. is making significant strides in the field of neuroplasticity as it embarks on a groundbreaking study focused on treating Alcohol Use Disorder (AUD). This endeavor is backed by a notable Small Business Innovation Research Grant, which aims to propel the development of a novel neuroplastogen toward...

Continue Reading
Fazoli’s Unveils Exciting New Lasagna Roll Options for Fans

Updated Category News Views 287

Fazoli’s Innovates with New Lasagna Roll Offerings Fazoli’s, America’s favorite fast and fresh Italian restaurant chain, is kicking off the new year with an exciting culinary twist. The restaurant is thrilled to introduce its all-new Lasagna Rolls, available for a limited time. This fresh take on a classic dish is set to delight pasta enthusiasts looking for...

Continue Reading
Leadership Transitions at NBHWC: A New Era for Coaching

Updated Category News Views 135

Leadership Transitions at NBHWC The National Board for Health and Wellness Coaching (NBHWC) has announced significant leadership changes that position the organization toward a future focused on enhancing health and wellness coaching. This move underscores a commitment to advancing the profession through evidence-based educational standards and increased accessibility for...

Continue Reading